US Stock MarketDetailed Quotes

Rein Therapeutics (RNTX)

Watchlist
  • 1.660
  • -0.180-9.78%
Close Apr 24 16:00 ET
  • 1.660
  • 0.0000.00%
Post 20:01 ET
46.54MMarket Cap-0.85P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rein Therapeutics (RNTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-21.99%21.93M
-31.71%3.96M
-9.54%5.49M
-23.98%6.87M
-22.15%5.61M
83.16%28.11M
-20.61%5.8M
207.08%6.07M
334.57%9.04M
80.62%7.21M
Selling and administrative expenses
-21.36%10.9M
-20.89%1.96M
62.24%3.81M
-51.32%2.58M
-31.72%2.56M
22.07%13.86M
-53.56%2.48M
20.15%2.35M
179.87%5.3M
71.73%3.74M
-General and administrative expense
-21.36%10.9M
-20.89%1.96M
62.24%3.81M
-51.32%2.58M
-31.72%2.56M
22.07%13.86M
-53.56%2.48M
20.15%2.35M
179.87%5.3M
71.73%3.74M
Research and development costs
-22.59%11.03M
-39.77%2M
-54.84%1.68M
14.73%4.29M
-11.81%3.05M
257.00%14.25M
68.46%3.32M
16,818.18%3.72M
1,900.53%3.74M
91.33%3.46M
Operating profit
21.99%-21.93M
31.71%-3.96M
9.54%-5.49M
23.98%-6.87M
22.15%-5.61M
-83.16%-28.11M
20.61%-5.8M
-207.08%-6.07M
-334.57%-9.04M
-80.62%-7.21M
Net non-operating interest income expense
0.00%400K
Non-operating interest income
----
----
----
----
----
0.00%400K
----
----
----
----
Other net income (expense)
21.10%-28.65M
21.80%-28.72M
-139.73%-89K
-49.48%49K
17.39%108K
-4,888.32%-36.32M
-9,539.90%-36.73M
49.33%224K
-66.89%97K
111.65%92K
Gain on sale of security
----
----
----
----
----
50.00%300K
----
----
----
----
Special income (charges)
22.43%-28.7M
----
----
----
----
-3,887.07%-37M
-308,433.33%-37M
--0
--0
--0
-Less：Restructuring and merger&acquisition
----
----
----
----
----
--0
--0
--0
--0
--0
-Less:Impairment of capital assets
-22.43%28.7M
----
----
----
----
--37M
----
----
----
----
Other non- operating income (expenses)
-92.99%48K
-107.35%-20K
-139.73%-89K
-49.48%49K
17.39%108K
--685K
--272K
43.59%224K
-52.68%97K
-60.34%92K
Income before tax
21.49%-50.58M
23.15%-32.68M
4.55%-5.58M
23.71%-6.82M
22.66%-5.5M
-310.99%-64.43M
-483.89%-42.53M
-220.03%-5.85M
-400.39%-8.94M
-48.84%-7.11M
Income tax
53.89%-712K
-1.54M
Net income
20.69%-49.87M
22.00%-31.97M
4.55%-5.58M
23.71%-6.82M
22.66%-5.5M
-301.14%-62.88M
-462.69%-40.98M
-220.03%-5.85M
-400.39%-8.94M
-48.84%-7.11M
Net income continuous Operations
20.69%-49.87M
22.00%-31.97M
4.55%-5.58M
23.71%-6.82M
22.66%-5.5M
-301.14%-62.88M
-462.69%-40.98M
-220.03%-5.85M
-400.39%-8.94M
-48.84%-7.11M
Minority interest income
Net income attributable to the parent company
20.69%-49.87M
22.00%-31.97M
4.55%-5.58M
23.71%-6.82M
22.66%-5.5M
-299.71%-62.88M
-458.40%-40.98M
-220.03%-5.85M
-400.39%-8.94M
-48.84%-7.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.69%-49.87M
22.00%-31.97M
4.55%-5.58M
23.71%-6.82M
22.66%-5.5M
-299.71%-62.88M
-458.40%-40.98M
-220.03%-5.85M
-400.39%-8.94M
-48.84%-7.11M
Basic earnings per share
44.16%-1.96
44.55%-1.22
22.22%-0.21
37.78%-0.28
70.93%-0.25
-2.63%-3.51
-40.13%-2.2
32.50%-0.27
-15.38%-0.45
18.10%-0.86
Diluted earnings per share
44.16%-1.96
44.55%-1.22
22.22%-0.21
37.78%-0.28
70.93%-0.25
-2.63%-3.51
-40.13%-2.2
32.50%-0.27
-15.38%-0.45
18.10%-0.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -21.99%21.93M-31.71%3.96M-9.54%5.49M-23.98%6.87M-22.15%5.61M83.16%28.11M-20.61%5.8M207.08%6.07M334.57%9.04M80.62%7.21M
Selling and administrative expenses -21.36%10.9M-20.89%1.96M62.24%3.81M-51.32%2.58M-31.72%2.56M22.07%13.86M-53.56%2.48M20.15%2.35M179.87%5.3M71.73%3.74M
-General and administrative expense -21.36%10.9M-20.89%1.96M62.24%3.81M-51.32%2.58M-31.72%2.56M22.07%13.86M-53.56%2.48M20.15%2.35M179.87%5.3M71.73%3.74M
Research and development costs -22.59%11.03M-39.77%2M-54.84%1.68M14.73%4.29M-11.81%3.05M257.00%14.25M68.46%3.32M16,818.18%3.72M1,900.53%3.74M91.33%3.46M
Operating profit 21.99%-21.93M31.71%-3.96M9.54%-5.49M23.98%-6.87M22.15%-5.61M-83.16%-28.11M20.61%-5.8M-207.08%-6.07M-334.57%-9.04M-80.62%-7.21M
Net non-operating interest income expense 0.00%400K
Non-operating interest income --------------------0.00%400K----------------
Other net income (expense) 21.10%-28.65M21.80%-28.72M-139.73%-89K-49.48%49K17.39%108K-4,888.32%-36.32M-9,539.90%-36.73M49.33%224K-66.89%97K111.65%92K
Gain on sale of security --------------------50.00%300K----------------
Special income (charges) 22.43%-28.7M-----------------3,887.07%-37M-308,433.33%-37M--0--0--0
-Less：Restructuring and merger&acquisition ----------------------0--0--0--0--0
-Less:Impairment of capital assets -22.43%28.7M------------------37M----------------
Other non- operating income (expenses) -92.99%48K-107.35%-20K-139.73%-89K-49.48%49K17.39%108K--685K--272K43.59%224K-52.68%97K-60.34%92K
Income before tax 21.49%-50.58M23.15%-32.68M4.55%-5.58M23.71%-6.82M22.66%-5.5M-310.99%-64.43M-483.89%-42.53M-220.03%-5.85M-400.39%-8.94M-48.84%-7.11M
Income tax 53.89%-712K-1.54M
Net income 20.69%-49.87M22.00%-31.97M4.55%-5.58M23.71%-6.82M22.66%-5.5M-301.14%-62.88M-462.69%-40.98M-220.03%-5.85M-400.39%-8.94M-48.84%-7.11M
Net income continuous Operations 20.69%-49.87M22.00%-31.97M4.55%-5.58M23.71%-6.82M22.66%-5.5M-301.14%-62.88M-462.69%-40.98M-220.03%-5.85M-400.39%-8.94M-48.84%-7.11M
Minority interest income
Net income attributable to the parent company 20.69%-49.87M22.00%-31.97M4.55%-5.58M23.71%-6.82M22.66%-5.5M-299.71%-62.88M-458.40%-40.98M-220.03%-5.85M-400.39%-8.94M-48.84%-7.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.69%-49.87M22.00%-31.97M4.55%-5.58M23.71%-6.82M22.66%-5.5M-299.71%-62.88M-458.40%-40.98M-220.03%-5.85M-400.39%-8.94M-48.84%-7.11M
Basic earnings per share 44.16%-1.9644.55%-1.2222.22%-0.2137.78%-0.2870.93%-0.25-2.63%-3.51-40.13%-2.232.50%-0.27-15.38%-0.4518.10%-0.86
Diluted earnings per share 44.16%-1.9644.55%-1.2222.22%-0.2137.78%-0.2870.93%-0.25-2.63%-3.51-40.13%-2.232.50%-0.27-15.38%-0.4518.10%-0.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -